Fulcrum Pharma PLC
7 November 2001
For Immediate Release: 7 November 2001
FULCRUM PHARMA PLC
APPOINTS FINANCE DIRECTOR
Hemel Hempstead, UK: Fulcrum Pharma plc (LSE: FUL), the independent, drug
development company, today announces the recent appointment of Geoffrey Smith
as Finance Director. Geoffrey has been Financial Controller of Fulcrum since
the Company's admission to AIM in March 2000 - he now joins the Main Board
with immediate effect.
Geoffrey Smith (47) brings Fulcrum Pharma 17 years' experience of working in
Finance Director / Controller roles, in a range of companies, from a variety
of sectors - this has enabled him to gain a wide range of experience both in
the private and public sector. In addition to the position as Finance
Director of Fulcrum Pharma, Geoffrey is also Finance Director of AIM listed
RexOnline plc and Bank Restaurant Group plc.
Geoffrey qualified from KPMG in July 1979 and is an Associate of the Institute
of Chartered Accountants in England and Wales.
Commenting on the new board appointment, Dr Jon Court, Chief Executive Officer
said:
'Following a very successful period since our admission to AIM, Fulcrum is at
a stage of development where the finance role now requires a Main Board
position. I very much look forward to continuing to work with Geoffrey and
welcome him to the Fulcrum Board.'
Geoffrey Smith is, or has been within the last five years, a director of the
following companies:
Current:
Bank Restaurant Group plc
Captain O.M. Watts plc
Cinderhall Limited
Cinderhall Properties Limited
Commercial and Retail Investments plc
EuroIVA Limited
Hutchinson Design Intl. Limited
Moor End Estates Limited
New Venture Capital Trust Limited
Ozark London Limited
Proudcrest Limited
RexOnline plc
Travel Accessories Limited
www Strategies Limited
Past:
Abacus Capital Limited
Abacus Capital Development Limited
Audax Communications plc
Captain O.M. Watts Limited
Clifton Financial Associates plc
Forexia (UK) Limited
Masters of London Limited
Pennycat Trading Company Limited
Revelation Piccadilly Holdings plc
Revelation (Piccadilly) Limited
RPH Services Limited
SWP Holdings Limited
The Leading Edge Holdings Limited
The Leading Edge Retail Limited
Geoffrey Smith was a director of Roak Food Group Plc which went into
administrative receivership in June 1995 and was a director of Castles
Wisehouse Limited to which an Administrative Receiver was appointed in June
1990. Geoffrey Smith resigned as a director of Revelation Piccadilly Holdings
plc on 30 September 1998, which went into administrative receivership in March
1999.
For further information, please contact :
Fulcrum Pharma PLC 0700 392 1103
Jon Court, Chief Executive
Buchanan Communications 0207 466 5000
Nicola How / Louise Bolton
Notes to Editors:
Fulcrum Pharma plc is an independent, drug development company that is the
first to offer global virtual drug development and strategic outsourcing
services to the pharmaceutical industry.
The Company has expertise in the design, execution and delivery of drug
development programmes and relies on state of the art information technology
and infrastructure in the supply of its services.
Through Fulcrum's services to its clients, the Directors believe that there is
the capacity to deliver products faster and more efficiently to the global
pharmaceutical market. Fulcrum does this by using its skills in the design of
drug programmes that deliver the necessary information for decision-making and
product registration. In so doing, Fulcrum works closely with its clients to
meet their strategic R&D goals.
Fulcrum Pharma is listed on the Alternative Investment Market of the London
Stock Exchange having successfully floated in March 2000.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.